PolyPeptide Group AG (SIX: PPGN), a focused global CDMO for peptide-based active pharmaceutical ingredients, published today the invitation to the fourth annual General Meeting, which will take ...

PolyPeptide's path to reclaiming profitability that aligns with its peers is supported by significant growth drivers in the market, including demand for GLP-1 API. Barclays forecasts that fiscal ...

UBS analyst Tanya Hansalik maintained a Hold rating on PolyPeptide Group AG (PPGN – Research Report) today and set a price target of CHF19.00.

CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Media release – ad hoc announcement pursuant to Art. 53 ...

When connected together by a series of peptide bonds, amino acids form a polypeptide, another word for protein. The polypeptide will then fold into a specific conformation depending on the ...

Investing.com -- Shares of PolyPeptide Group AG (SWX:SIX:PPGN) fell by 12% following the release of their 2024 financial results, which revealed a miss on revenue expectations, although EBITDA ...

Investing.com -- Shares of PolyPeptide Group AG (SWX:SIX: PPGN) fell by 12% following the release of their 2024 financial results, which revealed a miss on revenue expectations, although EBITDA ...